Trial Profile
The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Tandospirone (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- Acronyms GATE
- Sponsors Alcon
- 29 Apr 2014 New trial record